MEDP
Undervalued by 52.9% based on the discounted cash flow analysis.
Market cap | $9.90 Billion |
---|---|
Enterprise Value | $9.36 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $13.06 |
Beta | 1.47 |
Outstanding Shares | 30,945,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 24.87 |
---|---|
PEG | 67.69 |
Price to Sales | 4.92 |
Price to Book Ratio | 12.5 |
Enterprise Value to Revenue | 4.52 |
Enterprise Value to EBIT | 22.01 |
Enterprise Value to Net Income | 25 |
Total Debt to Enterprise | 0.01 |
Debt to Equity | 0.15 |
No data
No data